NCT06643598

Brief Summary

The goal of this behavioral-interventional study is to learn if the Abecedarian Approach implemented virtually for children ages 0-5 with a history of Hypoxic Ischaemic Encephalopathy (HIE) and/or premature birth produces the same effects as when administered at in-person facilities.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for not_applicable

Timeline
47mo left

Started Jun 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jun 2025Mar 2030

First Submitted

Initial submission to the registry

October 10, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 16, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

June 3, 2025

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2030

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

4.7 years

First QC Date

October 10, 2024

Last Update Submit

March 24, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Parent Satisfaction Questionnaire

    Questionnaire measuring parent satisfaction with the intervention and effects given at the end of the virtual program. Responses as measured by answering either strongly agree, agree, disagree or strongly disagree. Responses will be measured at the end of the intervention at 60 months and reported as participant counts.

    Assessed at end of treatment (up to 60 months)

  • Number of Sessions Attended

    We will be taking attendance of sessions to measure parent compliance with the virtual program. Attendance will be taken for each live session (every other week) for the entire period of enrollment (260 weeks).

    Assessed biweekly from enrollment to end of treatment (up to 260 weeks)

Secondary Outcomes (6)

  • Bayley Assessment

    Data collected at 12, 24, 36, 48, and 60 month time points

  • Behavior Reporting Inventory of Executive Function - Preschool Version (BRIEF-P)

    Data collected at the 24, 36, 48, and 60 month time points

  • Pediatric Quality of Life Inventory (PedsQL)

    Data collected at baseline, 24, 36, 48 and 60 month time points

  • Early Executive Functions Questionnaire (EEFQ)

    Data collected at baseline, 12, and 24 month time points

  • NIH Baby/Infant and NIH Pediatric Toolbox

    Data collected at 12, 24, 36, 48, and 60-month time points

  • +1 more secondary outcomes

Study Arms (3)

Standard of Care Provided

NO INTERVENTION

In the No Intervention condition, at-risk children will receive the current standard of care, and no intervention.

Virtual Abecedarian Approach Intervention

EXPERIMENTAL

In the Virtual Abecedarian Approach Intervention, children will partake in the Abecedarian Approach Intervention through a virtual format.

Behavioral: Abecedarian Approach

Feasibility Group

EXPERIMENTAL

Participants will be in fewer sessions in order to assess whether the intervention is accepted by the parents.

Behavioral: Abecedarian Approach

Interventions

The Abecedarian Approach is an early childhood behavioral education program that aims to improve the learning and cognitive development of children in high-risk or at-risk communities. This study will test the efficacy of implementing this approach in a virtual format.

Feasibility GroupVirtual Abecedarian Approach Intervention

Eligibility Criteria

AgeUp to 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • IPNH-NDCP patients, including:
  • Term-born children diagnosed during the neonatal period with hypoxic-ischemic encephalopathy, or
  • premature children (born at less than 28 weeks gestational age).
  • Parent or legal guardian will also be enrolled as a participant
  • Parents must be English-speaking (able to provide consent and complete questionnaires).

You may not qualify if:

  • Not suitable for study participation due to other reasons at the discretion of the investigator.
  • Infants with chromosomal abnormalities, genetic syndromes (for example, such as Down Syndrome or Trisomy18) and major congenital malformations will be excluded.
  • Infants with vision impairment will also be excluded from the study, as our study procedures do require intact vision to be able to complete.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin Madison

Madison, Wisconsin, 53715, United States

RECRUITING

MeSH Terms

Conditions

Hypoxia-Ischemia, BrainPremature BirthCerebral PalsyNervous System Diseases

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesBrain Damage, Chronic

Study Officials

  • Melisa Carrasco McCaul, MD, PhD

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Melisa Carrasco McCaul, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2024

First Posted

October 16, 2024

Study Start

June 3, 2025

Primary Completion (Estimated)

March 1, 2030

Study Completion (Estimated)

March 1, 2030

Last Updated

March 27, 2026

Record last verified: 2026-03

Locations